Stay updated with breaking news from Nasdaq imnn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Imunon (NASDAQ:IMNN – Get Free Report) and Aridis Pharmaceuticals (NASDAQ:ARDS – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation and earnings. Analyst Ratings This is a breakdown of current […] ....
Imunon, Inc. (NASDAQ:IMNN – Get Free Report) was the recipient of a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 264,600 shares, an increase of 128.7% from the January 15th total of 115,700 shares. Based on an average daily volume of 51,300 shares, the […] ....
Shares of Imunon, Inc. (NASDAQ:IMNN – Get Free Report) shot up 8.5% during mid-day trading on Thursday . The stock traded as high as $0.58 and last traded at $0.56. 67,446 shares traded hands during mid-day trading, an increase of 18% from the average session volume of 56,993 shares. The stock had previously closed at […] ....
Imunon, Inc. (NASDAQ:IMNN – Get Free Report) saw a significant growth in short interest in December. As of December 15th, there was short interest totalling 13,900 shares, a growth of 139.7% from the November 30th total of 5,800 shares. Based on an average daily volume of 33,100 shares, the days-to-cover ratio is currently 0.4 days. […] ....
Imunon, Inc. (NASDAQ:IMNN – Free Report) – Stock analysts at Brookline Capital Management lifted their FY2023 EPS estimates for Imunon in a report released on Tuesday, November 14th. Brookline Capital Management analyst K. Dolliver now expects that the company will post earnings per share of ($2.25) for the year, up from their previous forecast of […] ....